Guggenheim Securities SMID Cap Biotech Conference Format: Fireside Chat and one-on-one investor meetings Presentation Date: February 5, 2025 Presentation Time: 2:30 PM Webcast: Click here ...

This study compares immune proteins and bioactive peptides in cow and camel milk, highlighting camel milk's lower allergenic ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including milk thistle, turmeric, and green tea, that target the tumor ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming ...

CVI Pharmaceuticals Ltd. has identified thyroid hormone receptor (THR)-β agonists reported to be useful for the treatment of atherosclerosis, hypercholesterolemia, hyperlipidemia, hepatic steatosis, ...

Unveiling the circuit organization and functional roles of endopiriform neurons projecting to the ventral CA1.

Viewed as a ‘mini me’ version of the all-conquering Telix Pharmaceuticals, the $60 million market cap Radiopharm Theranostics ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

The firm will pay $45 million upfront for several new targeted agents that it plans to pair with isotopes to develop both ...

Morphological profiling allows accurate identification of cell types in dense iPSC-derived cultures, allowing its use for quality control and differentiation monitoring.